|
CA1322749C
(en)
*
|
1987-01-28 |
1993-10-05 |
Ryuzo Ueno |
Prostaglandins of the d series, and tranquilizers and soporifics containing the same
|
|
US6420422B1
(en)
|
1987-09-18 |
2002-07-16 |
Sucampo Pharmaceuticals, Inc. |
Ocular hypotensive agents
|
|
US5236907A
(en)
*
|
1988-10-01 |
1993-08-17 |
R-Tech Ueno Ltd. |
Ocular hypotensive agents
|
|
JP2597629B2
(ja)
|
1988-02-26 |
1997-04-09 |
株式会社 上野製薬応用研究所 |
１３，１４−ジヒドロ−１５−ケトプロスタグランジン類の安定化
|
|
US5296504A
(en)
*
|
1988-09-06 |
1994-03-22 |
Kabi Pharmacia |
Prostaglandin derivatives for the treatment of glaucoma or ocular hypertension
|
|
ES2317964T5
(es)
*
|
1988-09-06 |
2015-02-20 |
Pfizer Health Ab |
Derivado de prostaglandina-F2alfa para el tratamiento de glaucoma o hipertensión ocular
|
|
US6187813B1
(en)
|
1990-04-10 |
2001-02-13 |
Pharmacia & Upjohn Aktiebolag |
Prostaglandin derivatives for the treatment of glaucoma or ocular hypertension
|
|
US5321128A
(en)
*
|
1988-09-06 |
1994-06-14 |
Kabi Pharmacia Ab |
Prostaglandin derivatives for the treatment of glaucoma or ocular hypertension
|
|
EP1300150A3
(en)
*
|
1988-09-06 |
2003-05-14 |
Pharmacia Aktiebolag |
Prostaglandin derivatives for the treatment of glaucoma or ocular hypertension
|
|
US5194429A
(en)
*
|
1988-10-01 |
1993-03-16 |
K.K. Ueno Seiyaku Oyo Kenkyujo |
Ocular hypotensive agents
|
|
EP0580268B1
(en)
*
|
1988-10-01 |
1998-01-14 |
R-Tech Ueno Ltd. |
Ocular hypotensive agents
|
|
ATE122563T1
(de)
*
|
1989-07-27 |
1995-06-15 |
Ueno Seiyaku Oyo Kenkyujo Kk |
Verwendung von 15-keto-prostansäure-derivaten zur herstellung eines medikaments für die verbesserung der ausscheidung des kaliumions.
|
|
US5234954A
(en)
*
|
1989-07-27 |
1993-08-10 |
K.K. Ueno Seiyaku Oyo Kenkyujo |
Treatment of hyperlipidemia with 15-keto-prostaglandin compounds
|
|
DE69018903T2
(de)
*
|
1989-08-09 |
1995-08-24 |
Ueno Seiyaku Oyo Kenkyujo Kk |
Verwendung von Prostansäurederivaten zur Herstellung von Arzneimitteln zur Verbesserung der Ausscheidung von Nichtprotein in die Därme.
|
|
CA2027814C
(en)
*
|
1989-10-20 |
1996-07-30 |
Ryuji Ueno |
Treatment of hepatobiliary disease with 15-keto-prostaglandin compounds
|
|
US5256696A
(en)
*
|
1989-11-22 |
1993-10-26 |
Kabushikikaisha Ueno Seiyaku Oyo Kenkyujo |
Treatment of cardiac dysfunction with 15-ketoprostaglandin compounds
|
|
US5254588A
(en)
*
|
1989-11-22 |
1993-10-19 |
Kabushikikaisha Ueno Seiyaku Oyo Kenkyujo |
Treatment of pulmonary dysfunction with 15-ketoprostaglandin compounds
|
|
CA2030345C
(en)
*
|
1989-11-22 |
1998-12-08 |
Ryuji Ueno |
Use of 15-keto-prostaglandin compound for improvement of encephalic function
|
|
JP3164368B2
(ja)
*
|
1990-03-08 |
2001-05-08 |
塩野義製薬株式会社 |
１５―デオキシプロスタグランジン誘導体
|
|
TW224942B
(GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
*
|
1990-04-04 |
1994-06-11 |
Adka Ueno Kk |
|
|
CA2041417C
(en)
*
|
1990-05-01 |
2002-05-21 |
Ryuji Ueno |
Treatment of pancreatic disease with 15-keto-prostaglandin compounds
|
|
ES2059058T3
(es)
*
|
1990-05-22 |
1994-11-01 |
R Tech Ueno Ltd |
Combinacion sinergica para uso oftalmico.
|
|
CA2042937C
(en)
*
|
1990-05-22 |
2002-04-30 |
Ryuji Ueno |
Treatment of ocular hypertension with a synergistic combination
|
|
ES2069823T3
(es)
*
|
1990-05-22 |
1995-05-16 |
R Tech Ueno Ltd |
Tratamiento de la hipertension ocular con una combinacion sinergica ocular.
|
|
US5208256A
(en)
*
|
1990-05-22 |
1993-05-04 |
R-Tech Ueno, Ltd. |
Treatment of ocular hypertension with a synergistic combination for ocular administration
|
|
US5175189A
(en)
*
|
1990-05-22 |
1992-12-29 |
K.K. Ueno Seiyaku Oyo Kenkyujo |
Treatment of ocular hypertension with a synergistic combination for ophthalmic use
|
|
CA2046069C
(en)
*
|
1990-07-10 |
2002-04-09 |
Ryuji Ueno |
Treatment of inflammatory diseases with 15-keto-prostaglandin compounds
|
|
US5270049A
(en)
*
|
1990-11-09 |
1993-12-14 |
Allergan, Inc. |
2-decarboxyl-2-aminoalkyl-prostaglandins as ocular hypotensives
|
|
US5139491A
(en)
*
|
1990-12-06 |
1992-08-18 |
Allergan, Inc. |
2-decarboxyl-2-alkoxyalkyl prostaglandins as ocular hypotensives
|
|
TW210287B
(GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
*
|
1991-03-01 |
1993-08-01 |
Kabushikaisha Ueno Seiyaku Oyo Kenkyujo |
|
|
ATE141794T1
(de)
*
|
1991-03-14 |
1996-09-15 |
R Tech Ueno Ltd |
Stimulierung von wundheilung mit 15-keto- prostaglandinverbindungen
|
|
US5221690A
(en)
*
|
1991-10-02 |
1993-06-22 |
R-Tech Ueno Ltd. |
Increasing the choroidal blood flow
|
|
EP0668076B1
(en)
*
|
1992-08-26 |
2002-09-04 |
Sucampo AG |
Stabilization of a prostanoic acid compound
|
|
FR2707295A1
(fr)
*
|
1993-06-07 |
1995-01-13 |
Rhone Poulenc Agrochimie |
Fongicides pyrazoles substitués en position 3 par un hétérocycle.
|
|
US5510383A
(en)
*
|
1993-08-03 |
1996-04-23 |
Alcon Laboratories, Inc. |
Use of cloprostenol, fluprostenol and their salts and esters to treat glaucoma and ocular hypertension
|
|
US6184250B1
(en)
|
1993-08-03 |
2001-02-06 |
Alcon Laboratories, Inc. |
Use of cloprostenol and fluprostenol analogues to treat glaucoma and ocular hypertension
|
|
US5387608A
(en)
*
|
1993-08-17 |
1995-02-07 |
Allergan, Inc. |
Cyclopentane(ene) heptanoic or cyclopentane(ene) heptenoic acid, 2-hydrocarbyl sulfonamidomethyl and derivatives thereof as therapeutic agents
|
|
JP2769294B2
(ja)
*
|
1993-12-15 |
1998-06-25 |
アルコン ラボラトリーズ インコーポレイテッド |
局所的眼薬組成物及びそのためのプロスタグランジン化合物
|
|
US5807892A
(en)
*
|
1994-09-30 |
1998-09-15 |
Alcon Laboratories, Inc. |
Use of certain prostaglandin analogues to treat glaucoma and ocular hypertension
|
|
TW420611B
(en)
*
|
1995-03-10 |
2001-02-01 |
R Tech Ueno Ltd |
Pharmaceutical composition containing prostanoic acid compounds for the treatment of optic nerve disorder
|
|
WO1997023225A1
(en)
*
|
1995-12-22 |
1997-07-03 |
Alcon Laboratories, Inc. |
Combinations of dp and fp type prostaglandins for lowering iop
|
|
US6680339B2
(en)
|
1996-11-12 |
2004-01-20 |
Alcon Manufacturing, Ltd. |
15-fluoro prostaglandins as ocular hypotensives
|
|
CA2269853A1
(en)
|
1996-11-12 |
1998-05-22 |
Paul W. Zinke |
Use of cis-.delta.4 analogs of prostaglandins as ocular hypotensives
|
|
CA2269855A1
(en)
*
|
1996-11-12 |
1998-05-22 |
Alcon Laboratories, Inc. |
15-fluoro prostaglandins as ocular hypotensives
|
|
WO1998033497A1
(en)
|
1997-02-04 |
1998-08-06 |
Johnstone Murray A |
Method of enhancing hair growth
|
|
WO1998039293A2
(en)
|
1997-03-07 |
1998-09-11 |
Alcon Laboratories, Inc. |
13-thia prostaglandins for use in glaucoma therapy
|
|
US6770675B2
(en)
|
1997-03-17 |
2004-08-03 |
Novartis Ag |
Compositions and methods for reducing ocular hypertension
|
|
DE69834638T2
(de)
|
1997-10-13 |
2007-05-10 |
R-Tech Ueno, Ltd. |
Zusammensetzung zur Behandlung von Augenhypertension oder Glaukom
|
|
US6156785A
(en)
*
|
1998-01-23 |
2000-12-05 |
Merck Sharp & Dohme B.V. |
Method for increasing oxygen tension in the optic nerve and retina
|
|
US6096783A
(en)
*
|
1998-12-15 |
2000-08-01 |
Alcon Laboratories, Inc. |
Cyclobutane prostaglandin analogues as ocular hypotensive agents
|
|
JP5011548B2
(ja)
*
|
1998-12-25 |
2012-08-29 |
株式会社アールテック・ウエノ |
高眼圧症あるいは緑内障の処置用医薬組成物
|
|
SE9900672D0
(sv)
|
1999-02-25 |
1999-02-25 |
Synphora Ab |
Method and composition for prevention of scar formation in glaucoma filtration bleb and drainage fistula
|
|
CN1350521A
(zh)
|
1999-03-05 |
2002-05-22 |
宝洁公司 |
C16不饱和的fp选择性前列腺素类似物
|
|
TWI225398B
(en)
|
1999-07-14 |
2004-12-21 |
R Tech Ueno Ltd |
Composition for treatment of external secretion disorders
|
|
US6576663B2
(en)
|
1999-12-22 |
2003-06-10 |
Alcon, Inc. |
6-Keto prostaglandin F1α and analogs for treating dry eye
|
|
US6545036B2
(en)
|
2000-01-18 |
2003-04-08 |
Merck & Co., Inc. |
Ophthalmic compositions for treating ocular hypertension
|
|
US6548535B2
(en)
|
2000-01-18 |
2003-04-15 |
Merck & Co., Inc. |
Method for treating ocular hypertension
|
|
JP2003526660A
(ja)
*
|
2000-03-16 |
2003-09-09 |
スカンポ・アクチェンゲゼルシャフト |
高眼圧症および緑内障の治療
|
|
US6458836B1
(en)
|
2000-03-16 |
2002-10-01 |
Sucampo, A.G. |
Treatment of ocular hypertension and glaucoma
|
|
EP1267882B1
(en)
*
|
2000-03-24 |
2009-04-15 |
Sucampo AG |
Prostaglandins for the treatment of eye disease caused by light irradiation like photoretinitis
|
|
US20020146439A1
(en)
*
|
2000-03-31 |
2002-10-10 |
Delong Mitchell Anthony |
Compositions and methods for treating hair loss using oximyl and hydroxylamino prostaglandins
|
|
US20020172693A1
(en)
|
2000-03-31 |
2002-11-21 |
Delong Michell Anthony |
Compositions and methods for treating hair loss using non-naturally occurring prostaglandins
|
|
US20020013294A1
(en)
|
2000-03-31 |
2002-01-31 |
Delong Mitchell Anthony |
Cosmetic and pharmaceutical compositions and methods using 2-decarboxy-2-phosphinico derivatives
|
|
US20020037914A1
(en)
|
2000-03-31 |
2002-03-28 |
Delong Mitchell Anthony |
Compositions and methods for treating hair loss using C16-C20 aromatic tetrahydro prostaglandins
|
|
PE20020146A1
(es)
*
|
2000-07-13 |
2002-03-31 |
Upjohn Co |
Formulacion oftalmica que comprende un inhibidor de ciclooxigenasa-2 (cox-2)
|
|
US20020035148A1
(en)
*
|
2000-07-20 |
2002-03-21 |
Ryuji Ueno |
Treatment of ocular hypertension
|
|
US6414021B1
(en)
*
|
2000-08-25 |
2002-07-02 |
Sucampo Ag |
Control of intraocular pressure during surgery
|
|
US20040097592A1
(en)
*
|
2000-09-13 |
2004-05-20 |
Kenji Morishima |
Eye drops
|
|
US6291522B1
(en)
*
|
2000-09-27 |
2001-09-18 |
Allergan Sales, Inc. |
Cyclopentane heptan(ENE)oic acid, 2-thiocarbamoyloxy and 2-carbamoyloxy compounds as therapeutic agents
|
|
US20040254230A1
(en)
*
|
2001-12-03 |
2004-12-16 |
Ogidigben Miller J. |
Method for treating ocular hypertension
|
|
US7351404B2
(en)
|
2002-02-04 |
2008-04-01 |
Allergan, Inc. |
Method of enhancing hair growth
|
|
US8758733B2
(en)
|
2002-02-04 |
2014-06-24 |
Allergan, Inc. |
Topical treatment for chemotherapy induced eyelash loss or hypotrichosis using prostamide F2 alpha agonists
|
|
US9216183B2
(en)
|
2002-02-04 |
2015-12-22 |
Allergan, Inc. |
Topical treatment for chemotherapy induced eyelash loss or hypotrichosis using prostamide F2 alpha agonists
|
|
US20050124595A1
(en)
*
|
2002-03-15 |
2005-06-09 |
Goetz Michael A. |
Compositions and methods for treating glaucoma and ocular hypertension
|
|
EP1513523A1
(en)
*
|
2002-06-06 |
2005-03-16 |
Merck Frosst Canada & Co. |
1,5-disubstituted imidazolidin-2-one derivatives for use as ep4 receptor agonists in the treatment of eye and bone diseases
|
|
JP2005532363A
(ja)
*
|
2002-06-14 |
2005-10-27 |
メルク エンド カムパニー インコーポレーテッド |
高眼圧を治療するための眼用組成物
|
|
US20050239787A1
(en)
*
|
2002-06-17 |
2005-10-27 |
Goetz Michael A |
Novel maxi-k channel blockers, methods of use and process for making the same
|
|
JP2005532361A
(ja)
*
|
2002-06-17 |
2005-10-27 |
メルク エンド カムパニー インコーポレーテッド |
高眼圧症の治療用の眼科用組成物
|
|
JP2005533055A
(ja)
*
|
2002-06-17 |
2005-11-04 |
メルク エンド カムパニー インコーポレーテッド |
新規マキシｋチャンネルブロッカー、その使用方法および製造方法
|
|
US8580851B2
(en)
*
|
2002-08-21 |
2013-11-12 |
Sucampo Ag |
Ophthalmic solution
|
|
JP2006504679A
(ja)
*
|
2002-08-28 |
2006-02-09 |
メルク フロスト カナダ アンド カンパニー |
緑内障の治療においてｅｐ４受容体作動薬として使用するためのオキサゾリジン−２−オンおよびチアゾリジン−２−オン誘導体
|
|
TWI350170B
(en)
*
|
2002-08-29 |
2011-10-11 |
Santen Pharmaceutical Co Ltd |
Treating agent for glaucoma comprising rho kinase inhibitor and prostaglandin
|
|
EP1558602A2
(en)
*
|
2002-10-25 |
2005-08-03 |
Merck Frosst Canada Inc. |
2-pyrrolidones as ep4 receptor agonists
|
|
KR101103141B1
(ko)
|
2002-11-18 |
2012-01-04 |
산텐 세이야꾸 가부시키가이샤 |
Ｒｈｏ 키나아제 억제제와 β 차단약으로 이루어진 녹내장치료제
|
|
WO2004087051A2
(en)
*
|
2003-03-27 |
2004-10-14 |
Merck & Co., Inc. |
Ophthalmic compositions for treating ocular hypertension
|
|
EP1666043B1
(en)
*
|
2003-07-31 |
2009-12-02 |
Santen Pharmaceutical Co., Ltd. |
Product containing prostaglandin
|
|
TWI348386B
(en)
*
|
2003-08-12 |
2011-09-11 |
R Tech Ueno Ltd |
Composition and method for promoting hair growth
|
|
KR101091461B1
(ko)
*
|
2003-11-07 |
2011-12-07 |
센주 세이야꾸 가부시키가이샤 |
프로스타글란딘 함유 의약 조성물
|
|
RU2429849C2
(ru)
*
|
2004-12-09 |
2011-09-27 |
Сантен Фармасьютикал Ко., Лтд |
Продукт, содержащий простагландин, имеющий в своей молекуле атом фтора
|
|
SI1829545T1
(sl)
*
|
2004-12-24 |
2012-08-31 |
Santen Pharmaceutical Co Ltd |
Produkti, vsebujoči prostaglandin F2 alfa derivat
|
|
EP1830793A1
(en)
*
|
2004-12-29 |
2007-09-12 |
R-Tech Ueno, Ltd. |
Composition and method for scalp and hair treatment
|
|
AR055038A1
(es)
*
|
2005-03-04 |
2007-08-01 |
Sucampo Ag |
Metodo y compuesto para tratar enfermedades vasculares perifericas
|
|
JP4648340B2
(ja)
*
|
2006-02-07 |
2011-03-09 |
株式会社アールテック・ウエノ |
１５−ケトプロスタグランジンｅ誘導体の製造法
|
|
EP1994933B1
(en)
*
|
2006-03-13 |
2017-04-26 |
R-Tech Ueno, Ltd. |
Aqueous composition
|
|
US20090018204A1
(en)
*
|
2007-07-13 |
2009-01-15 |
Brinkenhoff Michael C |
Composition and method for enhancing hair growth
|
|
US7705001B2
(en)
*
|
2008-03-18 |
2010-04-27 |
Allergan, Inc |
Therapeutic substituted gamma lactams
|
|
AU2009239372B2
(en)
|
2008-04-24 |
2013-09-19 |
Allergan, Inc. |
Substituted gamma lactams as therapeutic agents
|
|
BRPI0910741A2
(pt)
*
|
2008-04-24 |
2015-09-29 |
Allergan Inc |
arilciclopentenos substituídos como agonistas de prostaglantina ep2
|
|
US8722739B2
(en)
|
2008-10-29 |
2014-05-13 |
Novaer Holdings, Inc. |
Amino acid salts of prostaglandins
|
|
US8623918B2
(en)
|
2008-10-29 |
2014-01-07 |
Novaer Holdings, Inc. |
Amino acid salts of prostaglandins
|
|
US20100204335A1
(en)
*
|
2008-12-01 |
2010-08-12 |
Allergan, Inc. |
Kit and composition for eyelash growth
|
|
US20110293549A1
(en)
|
2009-02-03 |
2011-12-01 |
Athena Cosmetics, Inc. |
Composition, method and kit for enhancing hair
|
|
US8609729B2
(en)
*
|
2009-04-15 |
2013-12-17 |
Sucampo Ag |
Method for treating macular degeneration
|
|
US20110124736A1
(en)
|
2009-11-09 |
2011-05-26 |
Allergan, Inc. |
Compositions and methods for stimulating hair growth
|
|
US9149484B2
(en)
|
2009-11-09 |
2015-10-06 |
Allergan, Inc. |
Compositions and methods for stimulating hair growth
|
|
WO2012018324A1
(en)
|
2010-08-02 |
2012-02-09 |
Athena Cosmetics, Inc. |
Composition, method and kit for enhancing hair
|
|
US8859616B2
(en)
|
2011-01-21 |
2014-10-14 |
Allergan, Inc. |
Compounds and methods for enhancing hair growth
|
|
JPWO2012105674A1
(ja)
|
2011-02-04 |
2014-07-03 |
興和株式会社 |
緑内障予防又は治療のための薬物療法
|
|
CN103561748A
(zh)
|
2011-04-07 |
2014-02-05 |
苏坎波公司 |
治疗眼疲劳的方法
|
|
TWI619497B
(zh)
*
|
2011-08-05 |
2018-04-01 |
Sucampo Ag |
精神分裂症的處置方法
|
|
AR092821A1
(es)
|
2012-04-20 |
2015-05-06 |
Sucampo Ag |
Conjugado de derivado de acido graso-polimero
|
|
US11285163B2
(en)
|
2014-10-20 |
2022-03-29 |
Sentiss Pharma Private Limited |
Ophthalmic solution
|